Osteoconductivity and osteoinductivity of NanoFUSE® DBM

Cell and Tissue Banking

Volumn 14, Issue 1, 2013, Pages 33-44

  Kirk, James F ^a   Ritter, Gregg ^a   Waters, Chad ^a   Narisawa, Sonoko ^b   Millán, José Luis ^b   Talton, James D ^a  

^a NANO ADM Advanced Development and Manufacturing Center   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Bioactive glass; Demineralized bone matrix; Osteoconductivity; Osteoinductivity

Indexed keywords

EID: 84873701790     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-012-9297-1     Document Type: Article

References (38)

1. Berven S, Tay BK, Kleinstueck FS, Bradford DS (2001) Clinical applications of bone graft substitutes in spine surgery: consideration of mineralized and demineralized preparations and growth factor supplementation. Eur Spine J 10(Suppl 2):S169-S177. doi: 10.1007/s005860100270
2. Biswas D, Bible JE, Whang PG, Miller CP, Jaw R, Miller S, Grauer JN (2010) Augmented demineralized bone matrix: a potential alternative for posterolateral lumbar spinal fusion. Am J Orthop 39(11):531-538
3. Cornell CN (1999) Osteoconductive materials and their role as substitutes for autogenous bone grafts. Orthop Clin North Am 30(4):591-598
4. Edwards JT, Diegmann MH, Scarborough NL (1998) Osteoinduction of human demineralized bone: characterization in a rat model. Clin Orthop Relat Res 357:219-228
5. Fujishiro Y, Hench LL, Oonishi H (1997) Quantitative rates of in vivo bone generation for Bioglass and hydroxyapatite particles as bone graft substitute. J Mater Sci Mater Med 8(11):649-652
6. Glowacki J, Kaban LB, Murray JE, Folkman J, Mulliken JB (1981) Application of the biological principle of induced osteogenesis for craniofacial defects. Lancet 1(8227):959-962
7. Goulet JA, Senunas LE, DeSilva GL, Greenfield ML (1997) Autogenous iliac crest bone graft. Complications and functional assessment. Clin Orthop Relat Res 339:76-81
8. Hattar S, Berdal A, Asselin A, Loty S, Greenspan DC, Sautier JM (2002) Behaviour of moderately differentiated osteoblast-like cells cultured in contact with bioactive glasses. Eur Cells Mater 4:61-69
9. Heary RF, Schlenk RP, Sacchieri TA, Barone D, Brotea C (2002) Persistent iliac crest donor site pain: independent outcome assessment. Neurosurgery 50(3):510-516 discussion 516-517
10. Hench LL, Paschall HA (1973) Direct chemical bond of bioactive glass-ceramic materials to bone and muscle. J Biomed Mater Res 7(3):25-42. doi: 10.1002/jbm.820070304
11. Hench LL, Xynos ID, Polak JM (2004) Bioactive glasses for in situ tissue regeneration. J Biomater Sci Polym Ed 15(4):543-562
12. Hoylaerts MF, Ding L, Narisawa S, Van Kerckhoven S, Millan JL (2006) Mammalian alkaline phosphatase catalysis requires active site structure stabilization via the N-terminal amino acid microenvironment. Biochemistry 45(32):9756-9766. doi: 10.1021/bi052471+
13. Ito G, Matsuda T, Inoue N, Kamegai T (1987) A histological comparison of the tissue interface of bioglass and silica glass. J Biomed Mater Res 21(4):485-497. doi: 10.1002/jbm.820210408
14. Kasten P, Luginbuhl R, van Griensven M, Barkhausen T, Krettek C, Bohner M, Bosch U (2003) Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, beta-tricalcium phosphate and demineralized bone matrix. Biomaterials 24(15):2593-2603
15. Kitsugi T, Nakamura T, Yamamura T, Kokubu T, Shibuya T, Takagi M (1987) SEM-EPMA observation of three types of apatite-containing glass-ceramics implanted in bone: the variance of a Ca-P-rich layer. J Biomed Mater Res 21(10):1255-1271. doi: 10.1002/jbm.820211008
16. Kokubo T, Ito S, Huang ZT, Hayashi T, Sakka S, Kitsugi T, Yamamuro T (1990) Ca, P-rich layer formed on high-strength bioactive glass-ceramic A-W. J Biomed Mater Res 24(3):331-343. doi: 10.1002/jbm.820240306
17. Logeart-Avramoglou D, Anagnostou F, Bizios R, Petite H (2005) Engineering bone: challenges and obstacles. J Cell Mol Med 9(1):72-84
18. Mauney JR, Blumberg J, Pirun M, Volloch V, Vunjak-Novakovic G, Kaplan DL (2004a) Osteogenic differentiation of human bone marrow stromal cells on partially demineralized bone scaffolds in vitro. Tissue Eng 10(1-2):81-92. doi: 10.1089/107632704322791727
19. Mauney JR, Sjostorm S, Blumberg J, Horan R, O'Leary JP, Vunjak-Novakovic G, Volloch V, Kaplan DL (2004b) Mechanical stimulation promotes osteogenic differentiation of human bone marrow stromal cells on 3-D partially demineralized bone scaffolds in vitro. Calcif Tissue Int 74(5):458-468. doi: 10.1007/s00223-003-0104-7
20. Morone MA, Boden SD (1998) Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel. Spine (Phila Pa 1976) 23(2):159-167
21. Mulliken JB, Glowacki J, Kaban LB, Folkman J, Murray JE (1981) Use of demineralized allogeneic bone implants for the correction of maxillocraniofacial deformities. Ann Surg 194(3):366-372
22. Mulliken JB, Kaban LB, Glowacki J (1984) Induced osteogenesis - the biological principle and clinical applications. J Surg Res 37(6):487-496
23. Narisawa S, Hofmann MC, Ziomek CA, Millan JL (1992) Embryonic alkaline phosphatase is expressed at M-phase in the spermatogenic lineage of the mouse. Development 116(1):159-165
24. Oonishi H, Kushitani S, Yasukawa E, Iwaki H, Hench LL, Wilson J, Tsuji E, Sugihara T (1997) Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin Orthop Relat Res 334:316-325
25. Rosenthal RK, Folkman J, Glowacki J (1999) Demineralized bone implants for nonunion fractures, bone cysts, and fibrous lesions. Clin Orthop Relat Res 364:61-69
26. Sassard WR, Eidman DK, Gray PM, Block JE, Russo R, Russell JL, Taboada EM (2000) Augmenting local bone with Grafton demineralized bone matrix for posterolateral lumbar spine fusion: avoiding second site autologous bone harvest. Orthopedics 23(10):1059-1064 discussion 1064-1055
27. Tiedeman JJ, Garvin KL, Kile TA, Connolly JF (1995) The role of a composite, demineralized bone matrix and bone marrow in the treatment of osseous defects. Orthopedics 18(12):1153-1158
28. Ubhi CS, Morris DL (1984) Fracture and herniation of bowel at bone graft donor site in the iliac crest. Injury 16(3):202-203
29. Urist MR, Dowell TA (1968) Inductive substratum for osteogenesis in pellets of particulate bone matrix. Clin Orthop Relat Res 61:61-78
30. Urist MR, Strates BS (1970) Bone formation in implants of partially and wholly demineralized bone matrix. Including observations on acetone-fixed intra and extracellular proteins. Clin Orthop Relat Res 71:271-278
31. Urist MR, DeLange RJ, Finerman GA (1983) Bone cell differentiation and growth factors. Science 220(4598):680-686
32. Wheeler DL, Stokes KE, Hoellrich RG, Chamberland DL, McLoughlin SW (1998) Effect of bioactive glass particle size on osseous regeneration of cancellous defects. J Biomed Mater Res 41(4):527-533. doi: 10.1002/(SICI)1097- 4636(19980915)41:4<527:AID-JBM3>3.0.CO;2-E
33. Wheeler DL, Eschbach EJ, Hoellrich RG, Montfort MJ, Chamberland DL (2000) Assessment of resorbable bioactive material for grafting of critical-size cancellous defects. J Orthop Res 18(1):140-148. doi: 10.1002/jor.1100180120
34. Wilson J, Pigott GH, Schoen FJ, Hench LL (1981) Toxicology and biocompatibility of bioglasses. J Biomed Mater Res 15(6):805-817. doi: 10.1002/jbm.820150605
35. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM (2000a) Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 276(2):461-465. doi: 10.1006/bbrc.2000.3503
36. Xynos ID, Hukkanen MV, Batten JJ, Buttery LD, Hench LL, Polak JM (2000b) Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation In vitro: implications and applications for bone tissue engineering. Calcif Tissue Int 67(4):321-329. doi: 10.1007/s002230001134
37. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM (2001) Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res 55(2):151-157. doi: 10.1002/1097-4636(200105)55:2<151:AID-JBM1001>3.0.CO;2-D
38. Younger EM, Chapman MW (1989) Morbidity at bone graft donor sites. J Orthop Trauma 3(3):192-195